Reduced adipose tissue mass and hypoleptinemia in NOS deficient mice:: effect of LPS on plasma leptin and adiponectin concentrations

被引:25
作者
Gómez-Ambrosi, J
Becerril, S
Oroz, P
Zabalza, S
Rodríguez, A
Muruzábal, FJ
Archanco, M
Gil, MJ
Burrell, MA
Frühbeck, G
机构
[1] Univ Navarra, Univ Navarra Clin, Metab Res Lab, Edificio CIFA, Pamplona 31008, Spain
[2] Univ Navarra, Dept Histol & Pathol, E-31080 Pamplona, Spain
[3] Univ Navarra, Univ Navarra Clin, Dept Biochem, Pamplona 31008, Spain
[4] Univ Navarra, Univ Navarra Clin, Dept Endocrinol, Pamplona 31008, Spain
关键词
inducible NO synthase; adipose tissue; leptin; adiponectin; lipopolysaccharide;
D O I
10.1016/j.febslet.2004.10.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to evaluate the impact of the lack of inducible NO synthase (iNOS) on body weight and adipose tissue mass as well as on plasma leptin and adiponectin in basal conditions and 6 h after lipopolysaccharide (LPS) administration in mice. Body weight was not different among male, six-week-old wild-type (WT) and iNOS(-/-) animals. However, the amount of epididymal white adipose tissue (EWAT) in iNOS(-/-) mice was significantly reduced (P < 0.05). Circulating leptin and leptin mRNA in EWAT were decreased in iNOS(_/_) mice (P < 0.05 and P < 0.01, respectively). Plasma adiponectin and adiponectin mRNA were unchanged. LPS administration increased plasma leptin in both genotypes (P < 0.05). Neither genotype nor treatment changed plasma adiponectin. In summary, iNOS-/- mice exhibited normal body weight but reduced adipose mass accompanied by hypoleptinemia. Leptin responsiveness to LPS in iNOS(-/-) is preserved, showing that the LPS-induced rise in leptin is independent of the presence of functional iNOS. In addition, iNOS deficiency or LPS does not influence expression and circulating levels of adiponectin. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:351 / 356
页数:6
相关论文
共 48 条
  • [11] Pivotal role of nitric oxide in the control of blood pressure after leptin administration
    Frühbeck, G
    [J]. DIABETES, 1999, 48 (04) : 903 - 908
  • [12] Control of body weight:: a physiologic and transgenic perspective
    Frühbeck, G
    Gómez-Ambrosi, J
    [J]. DIABETOLOGIA, 2003, 46 (02) : 143 - 172
  • [13] The adipocyte:: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
    Frühbeck, G
    Gómez-Ambrosi, J
    Muruzábal, FJ
    Burrell, MA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (06): : E827 - E847
  • [14] Modulation of white adipose tissue lipolysis by nitric oxide
    Gaudiot, N
    Jaubert, AM
    Charbonnier, E
    Sabourault, D
    Lacasa, D
    Giudicelli, Y
    Ribière, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13475 - 13481
  • [15] Evidence for a functional nitric oxide synthase system in brown adipocyte nucleus
    Giordano, A
    Tonello, C
    Bulbarelli, A
    Cozzi, V
    Cinti, S
    Carruba, MO
    Nisoli, E
    [J]. FEBS LETTERS, 2002, 514 (2-3): : 135 - 140
  • [16] Gene expression profile of omental adipose tissue in human obesity
    Gómez-Ambrosi, J
    Catalán, V
    Diez-Caballero, A
    Martínez-Cruz, LA
    Gil, MJ
    García-Foncillas, J
    Cienfuegoas, JA
    Salvador, J
    Mato, JM
    Fruhbeck, G
    [J]. FASEB JOURNAL, 2004, 18 (01) : 215 - +
  • [17] ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS
    GREEN, LC
    WAGNER, DA
    GLOGOWSKI, J
    SKIPPER, PL
    WISHNOK, JS
    TANNENBAUM, SR
    [J]. ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) : 131 - 138
  • [18] Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters - A role for leptin in the anorexia of infection
    Grunfeld, C
    Zhao, C
    Fuller, J
    Pollock, A
    Moser, A
    Friedman, J
    Feingold, KR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (09) : 2152 - 2157
  • [19] Globular adiponectin upregulates nitric oxide production in vascular endothelial cells
    Hattori, Y
    Suzuki, M
    Hattori, S
    Kasai, K
    [J]. DIABETOLOGIA, 2003, 46 (11) : 1543 - 1549
  • [20] Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766